未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 Multitarget gas alarm system for high-performance and anti-interference chemical warfare agents simulants detection
Yuan, Yubin; Wu, Qiang; Jiao, Menglong; Wu, Haiyang; Liu, Weihua; Wang, Xuming; Bu, Xiangrui; Li, Gong; Han, Chuanyu; Hu, Long; Li, Xin; Wang, Xiaoli 分享 收藏 Combination of mentor-based and resident-based learning may benefit to improving the ability of clinical practice in resident training基于导师和基于住院医师的学习相结合，可能有助于提高住院医师培训中的临床实践能力。Li, Min; Liu, Tao; Wen, Yiqiong; Zhang, Min; Zhu, Wenye; Wang, Xuming; Hou, Yunjiao; Li, Lin; Zu, Anju; Sun, Shibo 分享 收藏 Preliminary results of GQ1005 in metastatic HER2-low expressing breast cancer and HER2 positive gastric cancerGQ1005在HER2低表达转移性乳腺癌和HER2阳性胃癌中的初步结果Deng, T.; Sun, Y.; Wang, B.; Zhang, J.; Zhou, C.; Wang, J.; Yang, H.; Yang, B.; Wei, J.; Lin, R.; Liu, J.; Li, E.; Ji, Y.; Wang, L.; Wang, X.; Li, Z.; Yang, Y. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 SKB264 (MK-2870) in previously treated hormone receptor-positive (HR+)/ HER2-negative metastatic breast cancer (mBC): Results from a phase I/II, single-arm, basket trialOuyang, Q.; Yin, Y.; Song, L.; Yan, M.; Wu, X.; Tong, Z.; Liu, Y.; Wang, X.; Jin, X.; Diao, Y.; Liu, G.; Ge, J.; Li, J. 分享 收藏 Proxalutamide plus endocrine therapy as a combination therapy in women with HR+/HER2-/AR+ metastatic breast cancer: A phase I studyLi, H.; Jiang, H.; Song, G.; Ran, R.; Wang, J.; Wang, X.; Huang, J.; Feng, J.; Zhang, L.; Zang, A.; Yang, H.; Pan, Y.; He, X.; Donng, M.; Tong, Y.; Wang, Z.; Shao, Z. 分享 收藏 Results from a first-in-human phase Ia/b study of LX-039, an oral selective estrogen receptor (ER) degrader (SERD), in postmenopausal patients with ER+, HER2-advanced breast cancer (ABC)Shen, W.; Hu, X.; Zhang, J.; Cao, J.; Yao, H.; Wang, X.; Chen, Y.; Du, Y.; Tao, Z.; Wang, L.; Hu, C.; Li, C. 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Highly Efficient Hydration of Epoxides under Atmospheric Pressure and Low Water/Epoxide Ratios by a Tunable Azolate Ionic Liquid through Anion-Cation Synergetic CatalysisZhao, Zhenyu; Lu, Jiawei; Lin, Wenjun; Wang, Xuming; Bai, Jiayi; Zheng, Xueqiu; Xie, Rixin; Shi, Guiling; Li, Haoran; Wang, Congmin 分享 收藏 CAPT: A multicenter randomized controlled trial of perioperative versus postoperative camrelizumab plus apatinib for resectable hepatocellular carcinomaCAPT: 围手术期与术后camrelizumab联合阿帕替尼治疗可切除肝细胞癌的多中心随机对照试验Bai, X.; Chen, Y.; Zhang, X.; Zhang, F.; Liang, X.; Zhang, C.; Wang, X.; Lu, B.; Yu, S.; Liang, T. 分享 收藏 分享 收藏 Final analysis of PUFFIN: A phase III, randomised double-blind, placebo (Pla)-controlled study of pertuzumab, trastuzumab and docetaxel (PHD) for Chinese patients (pts) with previously untreated HER2-positive locally recurrent or metastatic breast cancer (LR/MBC)Xu, B.; Li, W.; Zhang, Q.; Li, Q.; Wang, X.; Li, H.; Sun, T.; Yin, Y.; Zheng, H.; Feng, J.; Zhu, H.; Siddiqui, A.; Macharia, H. N.; Knott, A. 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
